Private company

Apeiron Capital Investment Corp.

American biological products company, incorporated in Delaware1

In its 2023 annual report the company says: “We are an early-stage blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a business combination with one or more businesses. Our management team has experience sourcing, acquiring, growing and monetizing companies in these industries.”34 It is headquartered in Boston, Massachusetts.1

Last updated Oct 20, 2026.

Overview

$6.6MNet income, fiscal 20222
  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersBoston, Massachusetts1
  • Incorporated inDE3
  • Business address175 Federal Street, Suite 875, Boston, Ma 021103
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income2-$1.2M in 2022+414% since 2021
-$1.5M-$1.0M-$500.0K02021: -$234.3K-$234.3K20212022: -$1.2M-$1.2M2022+414%
Net income2$6.6M in 2022+1253% since 2021
0$2.0M$4.0M$6.0M$8.0M2021: $486.5K$486.5K20212022: $6.6M$6.6M2022+1253%
Fiscal year202020212022
Operating income-$234.3K2-$1.2M2
Income before tax$486.5K2$7.2M2
Income tax$07$588.5K2
Net income$486.5K2$6.6M2

Compare Apeiron Capital Investment Corp. with another company

Corporate structure

Apeiron Capital Investment Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Apeiron Capital Investment Corp.

  • Castle Creek Arbitrage, LLC Filed SC 13G/A on Apeiron Capital Investment Corp., latest Jan 10, 2024 (2 filings since Feb 13, 2023)
  • AQR CAPITAL MANAGEMENT LLC Filed SC 13G on Apeiron Capital Investment Corp., latest Feb 14, 2023
  • Saba Capital Management, L.P. Filed SC 13G/A on Apeiron Capital Investment Corp., latest Feb 14, 2023 (4 filings since Nov 19, 2021)
  • SPRING CREEK CAPITAL LLC Filed SC 13G on Apeiron Capital Investment Corp., latest Feb 10, 2023
  • HIGHBRIDGE CAPITAL MANAGEMENT LLC Filed SC 13G/A on Apeiron Capital Investment Corp., latest Jan 25, 2023 (3 filings since Nov 19, 2021)
  • Beryl Capital Management LLC Filed SC 13G on Apeiron Capital Investment Corp., latest Dec 2, 2022
  • Apeiron Capital Sponsor, LLC Filed SC 13G on Apeiron Capital Investment Corp., latest Feb 8, 2022
  • Apeiron Capital Investment Corp. Boston, Massachusetts

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Apeiron Capital Investment Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$751.6K7 Dec 31, 2021

Leadership

Who has led Apeiron Capital Investment Corp., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Joel Shulman2021

Chief financial officer

  1. Grant Grigorian2021

Chief operating officer

  1. Eva Adosoglou2021
2025
Board members and other officers (5)

Timeline

  1. Aug 11, 20238-K Ended a material agreement; Other events16
  2. May 11, 20238-K Entered a material agreement; New debt or obligation17
  3. Mar 14, 20238-K Entered a material agreement18
  4. Mar 9, 20238-K Other events19
  5. Feb 6, 20238-K Listing notice or transfer20
  6. Dec 23, 20228-K Bylaws or fiscal year changed; Shareholder vote21
  7. Dec 16, 20228-K Other events22
  8. Nov 18, 20228-K Executive or director change; Director nominations; Other events23
  9. Dec 29, 20218-K Other events24
  10. Nov 18, 20218-K Other events25
  11. Nov 12, 20218-K Entered a material agreement; Unregistered sale of shares; Bylaws or fiscal year changed26
  12. Nov 8, 2021New chief executive Joel Shulman becomes CEO9

Filings

61 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 11 major events, 9 insider forms, 13 large holders, 21 other. The latest 20:

  1. Jan 10, 2024SC 13G/A AMENDMENT NO. 1 EDGAR
  2. Aug 11, 202315-12G EDGAR
  3. Aug 11, 2023RW EDGAR
  4. Aug 11, 2023425 EDGAR
  5. Aug 11, 20238-K EDGAR
  6. May 15, 202310-Q EDGAR
  7. May 11, 2023S-4 EDGAR
  8. May 11, 2023425 EDGAR
  9. May 11, 20238-K EDGAR
  10. Mar 30, 202310-K EDGAR
  11. Mar 14, 2023425 EDGAR
  12. Mar 14, 20238-K EDGAR
  13. Mar 9, 2023425 EDGAR
  14. Mar 9, 20238-K EDGAR
  15. Feb 14, 2023SC 13G AQR CAPITAL MANAGEMENT LLC EDGAR
  16. Feb 14, 2023SC 13G/A EDGAR
  17. Feb 13, 2023SC 13G EDGAR
  18. Feb 10, 2023SC 13G EDGAR
  19. Feb 6, 20238-K EDGAR
  20. Jan 25, 2023SC 13G/A APEIRON CAPITAL INVESTMENT CORP. EDGAR

The 61 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Apeiron Capital Investment Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARApeiron Capital Investment Corp.1
  • CIK0001849011
  • Employer ID (EIN)86-19635221
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address175 Federal Street, Suite 875, Boston, MA 021101
  • Phone61791726031
  • Public float$172.2M as of Jun 30, 20222
  • On EDGAR sinceMar 15, 20211
  • Filings74 in all: 8-K (11), SC 13G (9), 3 (8), S-1/A (6), SC 13G/A (6), 10-Q (5), CORRESP (5), 425 (4)1
    All 24 form types

    UPLOAD (4), 10-K (2), 15-12G (1), 25-NSE (1), 3/A (1), 424B4 (1), 8-A12B (1), CERT (1), DEF 14A (1), DEFA14A (1), DRS (1), EFFECT (1), PRE 14A (1), RW (1), S-1 (1), S-4 (1)

  • Latest filingsAnnual report (10-K) Mar 30, 2023
    Quarterly report (10-Q) May 15, 2023
    Proxy statement (DEF 14A) Dec 1, 2022
    Latest 8-K (8-K) Aug 11, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
    SEC EDGAROther events
  20. 20
  21. 21
  22. 22
    SEC EDGAROther events
  23. 23
  24. 24
    SEC EDGAROther events
  25. 25
    SEC EDGAROther events
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34